Monoamine oxidase-A (MAO-A) and MAO-B have both been implicated in the pathology of Alzheimer disease (AD). We examined 60 autopsied control and AD donor brain samples to determine how well MAO function aligned with two major risk factors for AD, namely sex and APOE ε4 status. MAO-A activity was increased in AD cortical, but not hippocampal, samples. In contrast, MAO-B activity was increased in both regions (with a strong input from female donors) whether sample means were compared based on: (a) diagnosis alone; (b) diagnosis-by-APOE ε4 status (i.e., carriers vs. non-carriers of the ε4 allele); or (c) APOE ε4 status alone (i.e., ignoring ‘diagnosis’ as a variable). Sample means strictly based on the donor’s sex did not reveal any difference...
© 2018 The Authors. Genes, Brain and Behavior published by International Behavioural and Neural Gene...
Late-onset Alzheimer’s disease (LOAD) likely results from combinations of risk factors that include ...
Alzheimer’s Disease (AD) is a complex neurodegenerative disease resulting from both environmental an...
<p>Monoamine oxidase-A (MAO-A) and MAO-B have both been implicated in the pathology of Alzheimer dis...
Background: The dopaminergic system is functionally compromised in Alzheimer's Disease (AD). The act...
The current study aimed to assess the pathophysiology mechanisms that mediate the effect on albin wi...
Background Increased levels of the pathogenic amyloid β-peptide (Aβ), released from its precursor b...
Presenilin-1 (PS-1) is the catalytic core of the ã-secretase complex, which is best known for its ro...
The enzyme monoamine oxidase (MAO) is linked to mental disorders such as depression and neurodegener...
Late-onset Alzheimer’s disease (AD) can, in part, be considered a metabolic disease. Besides age, fe...
International audienceAge, sex and APOE-ε4 genotype have been identified as the strongest predictors...
Despite not being utilized as considerably as other antidepressants in the therapy of depression, th...
Monoamine oxidases (MAO) influence the monoamine levels in brain by virtue of their role in neurotra...
The X-linked Monoamine Oxidase A (MAO A) gene presents a well known functional polymorphism consisti...
The genetic deletion of monoamine oxidase A (MAO A), an enzyme that breaks down the monoamine neurot...
© 2018 The Authors. Genes, Brain and Behavior published by International Behavioural and Neural Gene...
Late-onset Alzheimer’s disease (LOAD) likely results from combinations of risk factors that include ...
Alzheimer’s Disease (AD) is a complex neurodegenerative disease resulting from both environmental an...
<p>Monoamine oxidase-A (MAO-A) and MAO-B have both been implicated in the pathology of Alzheimer dis...
Background: The dopaminergic system is functionally compromised in Alzheimer's Disease (AD). The act...
The current study aimed to assess the pathophysiology mechanisms that mediate the effect on albin wi...
Background Increased levels of the pathogenic amyloid β-peptide (Aβ), released from its precursor b...
Presenilin-1 (PS-1) is the catalytic core of the ã-secretase complex, which is best known for its ro...
The enzyme monoamine oxidase (MAO) is linked to mental disorders such as depression and neurodegener...
Late-onset Alzheimer’s disease (AD) can, in part, be considered a metabolic disease. Besides age, fe...
International audienceAge, sex and APOE-ε4 genotype have been identified as the strongest predictors...
Despite not being utilized as considerably as other antidepressants in the therapy of depression, th...
Monoamine oxidases (MAO) influence the monoamine levels in brain by virtue of their role in neurotra...
The X-linked Monoamine Oxidase A (MAO A) gene presents a well known functional polymorphism consisti...
The genetic deletion of monoamine oxidase A (MAO A), an enzyme that breaks down the monoamine neurot...
© 2018 The Authors. Genes, Brain and Behavior published by International Behavioural and Neural Gene...
Late-onset Alzheimer’s disease (LOAD) likely results from combinations of risk factors that include ...
Alzheimer’s Disease (AD) is a complex neurodegenerative disease resulting from both environmental an...